normetanephrine has been researched along with Idiopathic Parkinson Disease in 6 studies
Normetanephrine: A methylated metabolite of norepinephrine that is excreted in the urine and found in certain tissues. It is a marker for tumors.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levodopa induced an increase of about 400 fold in urinary DA; DOPAC was increased about 300 fold, 3-MT only about 70 fold, but HVA about 300 fold." | 1.25 | Urinary excretion of monoamines and their metabolites in patients with Parkinson's disease. Response to long-term treatment with levodopa alone or in combination with a dopa decarboxylase inhibitor and clinical correlations. ( Rinne, UK; Siirtola, T; Sonninen, V, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eisenhofer, G | 2 |
| Brown, S | 1 |
| Peitzsch, M | 1 |
| Pelzel, D | 1 |
| Lattke, P | 1 |
| Glöckner, S | 1 |
| Stell, A | 1 |
| Prejbisz, A | 1 |
| Fassnacht, M | 1 |
| Beuschlein, F | 1 |
| Januszewicz, A | 1 |
| Siegert, G | 1 |
| Reichmann, H | 1 |
| Collier, A | 1 |
| Ghosh, S | 1 |
| Breckenridge, A | 1 |
| Perry, CG | 1 |
| Freel, EM | 1 |
| Davidson, DF | 2 |
| Goldstein, DS | 1 |
| Holmes, C | 1 |
| Sharabi, Y | 1 |
| Brentzel, S | 1 |
| Grosset, K | 1 |
| Grosset, D | 1 |
| Siirtola, T | 1 |
| Sonninen, V | 1 |
| Rinne, UK | 1 |
| Routh, JI | 1 |
| Bannow, RE | 1 |
| Fincham, RW | 1 |
| Stoll, JL | 1 |
1 trial available for normetanephrine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.
Topics: Adolescent; Adult; Aged; Antiparkinson Agents; Catecholamines; Creatinine; Dopamine; Female; Homovan | 2007 |
5 other studies available for normetanephrine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
Topics: Aged; Aged, 80 and over; Chromatography, Liquid; Dopamine; Epinephrine; Female; Humans; Levodopa; Ma | 2014 |
A phaeochromocytoma occurring in a patient with Parkinson's disease on L-dopa therapy: a diagnostic challenge.
Topics: Adrenal Gland Neoplasms; Antiparkinson Agents; Creatinine; Humans; Levodopa; Male; Metanephrine; Mid | 2012 |
Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension.
Topics: Adrenal Medulla; Aged; Autonomic Nervous System Diseases; Catechols; Epinephrine; Female; Heart Cond | 2003 |
Urinary excretion of monoamines and their metabolites in patients with Parkinson's disease. Response to long-term treatment with levodopa alone or in combination with a dopa decarboxylase inhibitor and clinical correlations.
Topics: 3,4-Dihydroxyphenylacetic Acid; Benserazide; Biogenic Amines; Dopamine; Female; Homovanillic Acid; H | 1975 |
Excretion of L-dopa and its metabolites in urine of Parkinson's disease patients receiving L-dopa therapy.
Topics: Aged; Aluminum; Chromatography; Chromatography, Ion Exchange; Colorimetry; Dihydroxyphenylalanine; D | 1971 |